Propanc Biopharma, Inc. (PPCB): Capital Expenditures

Annual figures by period end, from SEC filings.

$4.9K
Year ended 2026-06-30
-6.7%
10-year compound annual growth
$9.9K2011-06-30: $3.5K2014-06-30: $02015-06-30: $3.9K2016-06-30: $9.9K2019-06-30: $2.9K2026-06-30: $4.9K$4.9K
2011-06-30 Capital Expenditures (USD) 2026-06-30
Period endedCapital ExpendituresChange YoYSource filing
2026-06-30$4.9Kn/a2026-09-25, From 2025-07-01
No annual figure between 2019-06-30 and 2026-06-30.
2019-06-30$2.9Kn/a2020-10-01, From 2018-07-01
No annual figure between 2016-06-30 and 2019-06-30.
2016-06-30$9.9K+153.2%2017-09-28, From 2015-07-01
2015-06-30$3.9Kn/a2016-09-28, From 2014-07-01
2014-06-30$0n/a2015-09-30, From 2013-07-01
No annual figure between 2011-06-30 and 2014-06-30.
2011-06-30$3.5Kn/a2012-10-15, From 2010-07-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Propanc Biopharma, Inc. (PPCB)2026-06-30$4.9Kn/a
PMGC Holdings Inc. (ELAB)2025-12-31$442.3Kn/m
Imunon, Inc. (IMNN)2025-12-31$280.6K+849.8%
CalciMedica, Inc. (CALC)2025-12-31$28.0K+250.0%
PRF Technologies Ltd. (PRFX)2025-12-31$2.0K-84.6%
Chemomab Therapeutics Ltd. (CMMB)2025-12-31$3.0Kn/a
Exicure, Inc. (XCUR)2025-12-31$1.0Kn/a
NewcelX Ltd. (NCEL)2025-12-31$8.0K+33.3%
MetaVia Inc. (MTVA)2025-12-31$2.0K-75.0%

Compare PPCB, ELAB, IMNN, CALC side by side · Screen every company in Pharmaceutical Preparations ↗